ANTICOV Trial
An External Relations Officer at DNDi supports fundraising efforts by conducting prospect research, developing grant proposals, managing donor reporting, and coordinating grant management activities. The role involves both regional and global responsibilities, focusing on securing and stewarding resources for DNDi's mission.
The ANTICOV clinical trial aimed to identify treatments to treat mild and moderate cases of COVID-19 early and prevent hospitalizations in low-resource settings across Africa, Asia, and Latin America. Launched in September 2020 by a 27-organization consortium coordinated by the Drugs for Neglected Diseases initiative (DNDi), it was one of the largest multi-country trials focusing exclusively on mild and moderate COVID-19 cases. The study was completed in December 2022, and its collaborative momentum led to the creation of the PANTHER platform to strengthen pandemic preparedness in Africa.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ANTICOV Trial.
Foundation Relations Officer
Guiding Eyes for the Blind
Manager, Grants & External Relations
8a7883d0684a9984016857fb1a0f0f8b
Development Coordinator
Children's Rights
Specialist, Grant Writing and Prospect Research
YMCA of Oakville
Corporate and Foundation Relations Officer
Walsh University
Foundation, Corporation, and Research Manager | Philanthropy | Full Time
Concord Hospital Health System